FTC Workshop to Revisit Competition Issues Regarding Follow-On Biologics
By EsqSocial Corporation 21/11/13
Five years ago, the Federal Trade Commission (FTC) waded into the debate regarding the benefits and potential competition issues posed by the introduction of "follow-on biologics." Now, some three years after Congress provided a pathway for approval...
By: Wilson Sonsini Goodrich & Rosati